Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-12

Clinical Trial Update: Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glucocorticoids in combination with concurrent chemoradiotherapy for unresectable thymoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • glucocorticoids (glucocorticoids)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Thymoma | Phase 2 | Status: RECRUITING